搜索筛选:
搜索耗时4.7357秒,为你在为你在102,285,761篇论文里面共找到 9 篇相符的论文内容
类      型:
[期刊论文] 作者:Mingqiang Wang,Fuqiang Chen,Chaodong Zhu,Chunsheng Wu, 来源:黑龙江科技信息 年份:2019
本文通过对荣华二采区10...
[期刊论文] 作者:Mingqiang Wang,Fuqiang Chen,Chaodong Zhu,Chunsheng Wu, 来源:动物分类学报 年份:2021
Epipaschiinae,a subfamily of Pyralidae,has characteristic features distinct from other groups of Pyralidae,such as the thick scales and labial palpi usually upturned.This subfamily is a relative smaller group in Pyralidae,and currently repo......
[期刊论文] 作者:Ning Wenguo,Li Heng,Zhu Chunsheng,Luo Le,Chen Dong,Duan Zhenzhen, 来源:城市道桥与防洪 年份:2013
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥...
[期刊论文] 作者:Ying Zhu,Yongli He,Shanshan Jiang,Li Zhu,Chunsheng Chen,Qing Wan, 来源:半导体学报(英文版) 年份:2021
Since the invention of amorphous indium-gallium-zinc-oxide (IGZO) based thin-film transistors (TFTs) by Hideo Hosono in 2004,investigations on the topic of IGZO...
[期刊论文] 作者:Rui Liu,Yongli He,Shanshan Jiang,Li Zhu,Chunsheng Chen,Ying Zhu,Qing Wan, 来源:中国物理B(英文版) 年份:2021
Emulation of synaptic function by ionic/electronic hybrid device is crucial for brain-like computing and neuromor-phic systems.Electric-double-layer (EDL) trans...
[会议论文] 作者:Xianyang Zhu,Chunsheng Cui,Duanzhen Zhang,Qiguang Wang,Huoyuan Chen,Xiaotang Sheng,Junjun Gu,Po Zhang, 来源:2013中国心脏大会(CHC) 年份:2013
[会议论文] 作者:Xianyang Zhu,Chunsheng Cui,Duanzhen Zhang,Qiguang Wang,Huoyuan Chen,Xiaotang Sheng,Jun jun Gu,Po Zhang, 来源:中华医学会第十五次全国心血管病学大会 年份:2013
[会议论文] 作者:Xiaojuan Xin,Yunhua Liao,Yijiang Huang,Yunkui Zhu,Chunsheng Xi,Weili Zhang,Ling Zhong,Bei Jia,Wenxiang, 来源:中国药理学会第十一届全国化疗药理学术研讨会 年份:2012
Background Cettriaxone/sulbactam(4∶1)is a novel β-lactam/β-lactamase-inhibitor combination injection.A clinical study was designed to evaluate its efficacy and safety in the treatment of respiratory a...
[会议论文] 作者:Xiaojuan Xin,Yunhua Liao,Yijiang Huang,Yunkui Zhu,Chunsheng Xi,Weili Zhang,Ling Zhong,Bei Jia,Wenxiang, 来源:第四届国际人体微生态大会、第十三届中华预防医学会微生态学学术会议、第五届中国医师协会感染科医师大会暨传染病诊治高峰论坛、 年份:2013
Background Ceftriaxone/sulbactam (4:1) is a novel β-lactam/β-lactamase-inhibitor combination injection.A clinical study was designed to evaluate its efficacy and safety in the treatment of respiratory...
相关搜索: